Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.69 USD
Change Today -0.001 / -0.14%
Volume 122.7K
IMSC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 05/21/15 All times are local (Market data is delayed by at least 15 minutes).

implant sciences corp (IMSC) Snapshot

Open
$0.69
Previous Close
$0.69
Day High
$0.70
Day Low
$0.68
52 Week High
09/11/14 - $1.82
52 Week Low
04/28/15 - $0.66
Market Cap
51.4M
Average Volume 10 Days
130.6K
EPS TTM
$-0.34
Shares Outstanding
74.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMPLANT SCIENCES CORP (IMSC)

Related News

No related news articles were found.

implant sciences corp (IMSC) Related Businessweek News

No Related Businessweek News Found

implant sciences corp (IMSC) Details

Implant Sciences Corporation, together with its subsidiaries, develops, manufactures, and sells sensors and systems for the security, safety, and defense industries primarily in the United States and internationally. Its products include Quantum Sniffer QS-H150 portable explosives detector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time; and Quantum Sniffer QS-B220 desktop explosives and narcotics detector for the detection and identification of various military, commercial, and improvised explosives, as well as narcotics. Implant Sciences offers its products for use in aviation and transportation security, high threat facilities and infrastructure, military installations, customs and border protection, and mail and cargo screening. The company markets and sells its products through direct sales and marketing staff, as well as through a network of independent and specialized sales representatives, and distributors. Implant Sciences Corporation was founded in 1984 and is headquartered in Wilmington, Massachusetts.

74 Employees
Last Reported Date: 09/29/14
Founded in 1984

implant sciences corp (IMSC) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $270.0K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $230.0K
Vice President of Technology & Product Develo...
Total Annual Compensation: $200.0K
Vice President of Global Sales & Marketing
Total Annual Compensation: $245.0K
Compensation as of Fiscal Year 2014.

implant sciences corp (IMSC) Key Developments

Implant Sciences Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015

Implant Sciences Corporation announced unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2015. For the third quarter, the company reported revenues of $3,305,000 against $2,708,000 a year ago. The increase in revenue is due primarily to a 182.6% increase in the number of QS-B220 desktop units sold in the three months ended March 31, 2015, due to increased shipments to European, Latin American and U.S. air cargo screening facilities in the current three month period, offset partially by a 4.0% decrease in the average unit sales prices, which resulted in a 171.4% increase in QS-B220 revenues. The increased revenues achieved on sales of the QS-B220 were partially offset by a 40.9% decrease in the number of QS-H150 handheld units sold in the three months ended March 31, 2015, compared to the prior period, due to decreased shipments to Mexico, which is partially offset by a 5.6% increase in the average unit sales prices, which resulted in a 37.6% decrease in QS-H150 revenues.  Sales of parts and supplies decreased 1.3% in the three months ended March 31, 2015. Sales of QS-B220 were favorably impacted in the comparable prior period due to the acceptance of the QS-B220 into the qualified section of the TSA's Air Cargo Screening Technology List and achieving ECAC's Common Evaluation Process of Security Equipment for airport checkpoint screening of passengers and baggage. Loss from operations was $3,489,000 against $3,218,000 a year ago. Net loss was $5,731,000 against $4,939,000 a year ago. The increase in the net loss is primarily due to increased operating expenses and an increase in interest expense. Net loss per share, basic and diluted was $0.08 against $0.08 a year ago. Adjusted LBITDA was $2,266,000 against $2,299,000 a year ago. For the nine months, the company reported revenues of $7,315,000 against $7,023,000 a year ago. The increase in revenue is due primarily to a 23.3% increase in the number of QS-B220 desktop units sold in the nine months ended March 31, 2015, due to increased shipments to European, Latin American and U.S. air cargo screening facilities in the current nine month period, offset partially by a 4.9% decrease in the average unit sales prices, which resulted in a 17.2% increase in QS-B220 revenue.  The increased revenues achieved on sales of the QS-B220, were partially offset by a 7.8% decrease in the number of QS-H150 handheld units sold in the nine months ended March 31, 2015, compared to the prior period, due to decreased shipments to Mexico, and a 4.5% decrease in the average unit sales prices, which resulted in an 11.8% decrease in QS-H150 revenues.  Sales of parts and supplies increased 24.7% in the nine months ended March 31, 2015. Sales of QS-B220 were favorably impacted in the comparable prior period due to the acceptance of the QS-B220 into the qualified section of the TSA's Air Cargo Screening Technology List and achieving ECAC's Common Evaluation Process of Security Equipment for airport checkpoint screening of passengers and baggage. Competitive market conditions are expected to continue to have a negative impact on average unit sales prices for the foreseeable future. Loss from operations was $10,949,000 against $10,351,000 a year ago. Net loss was $17,350,000 against $15,341,000 a year ago. The increase in the net loss is primarily due to an increase in interest expense and increased operating expenses, primarily due to costs associated with the resignation of former CEO. Net loss per share, basic and diluted was $0.25 against $0.26 a year ago. Adjusted LBITDA was $8,109,000 against $6,897,000 a year ago.

Implant Sciences Corp. to Report Q3, 2015 Results on May 14, 2015

Implant Sciences Corp. announced that they will report Q3, 2015 results at 9:05 PM, GMT Standard Time on May 14, 2015

Implant Sciences Corp., Q3 2015 Earnings Call, May 14, 2015

Implant Sciences Corp., Q3 2015 Earnings Call, May 14, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMSC:US $0.69 USD -0.001

IMSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bruker Corp $19.04 USD -3.17
CR Bard Inc $172.38 USD -0.66
Safran SA €66.06 EUR +0.12
Thermo Fisher Scientific Inc $132.84 USD +0.82
View Industry Companies
 

Industry Analysis

IMSC

Industry Average

Valuation IMSC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPLANT SCIENCES CORP, please visit www.implantsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.